Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
26 Jun 2020
Markets for You
Global Indices
Global Indices 25-Jun Prev_Day Abs. Change
% Change
Russell 3000 1,537 1,519 18 1.22
Nasdaq 10,017 9,909 108 1.09
FTSE 6,147 6,124 23 0.38
Nikkei 22,260 22,534 -275 -1.22
Hang Seng
24,782 24,907 -126 -0.50
Indian Indices 25-Jun Prev_Day Abs. Change
% Change
S&P BSE Sensex 34,842 34,869 -27 -0.08
Nifty 50 10,289 10,305 -16 -0.16
Nifty 100 10,487 10,500 -13 -0.13
Nifty 500 8,500 8,496 4 0.04
Nifty Bank 21,506 21,427 79 0.37
S&P BSE Power 1,612 1,613 -1 -0.08
S&P BSE Small Cap
12,606 12,511 95 0.76
S&P BSE HC 16,580 16,421 159 0.97
Date P/E Div. Yield P/E Div. Yield
25-Jun 22.40 1.03 25.59 1.48
Month Ago 18.79 1.24 20.97 1.69
Year Ago 28.47 1.19 29.17 1.24
Nifty 50 Top 3 Gainers
Company 25-Jun Prev_Day
% Change
ITC 202 192 5.34
Kotak Bank 1382 1344 2.81
Hero Moto 2560 2494 2.64
Nifty 50 Top 3 Losers Domestic News
Company 25-Jun Prev_Day
% Change
Asian Paints 1689 1747 -3.33
Hindalco 147 151 -3.17
Indian Oil 85 87 -2.35
Advance Decline Ratio
Advances 1519 1034
Declines 1191 850
Unchanged 110 69
Institutional Flows (Equity)
Description (Cr)
FII Flows* -16931
MF Flows** 37947
Jun 2020; **18
Jun 2020
Economic Indicator
YoY(%) Current Year Ago
Data as on 24 Jun, 2020
Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
26 June 2020
Since May-17, MOSPI has revised base year of IIP & WPI from 2004-05 to 2011-12, and for CPI from
2010 to 2012
Indian Equity Market
Indices Performance
P/E Dividend Yield
Quarter Ago
Indian equity markets slipped marginally in a volatile session as downbeat
global economic growth outlook from the International Monetary Fund and
a surge in covid-19 cases weighed on the investor sentiment.
Key benchmark indices S&P BSE Sensex and Nifty 50 lost 0.08% and 0.16%
to close at 34,842.10 and 10,288.90 respectively. S&P BSE MidCap and S&P
BSE SmallCap gained 0.62% and 0.76% respectively.
The overall market breadth on BSE was strong with 1,519 scrips advancing
and 1,191 scrips declining. A total of 110 scrips remained unchanged.
On the BSE sectoral front, S&P BSE FMCG was the major gainer, up 2.25%
followed by S&P BSE Healthcare, up 0.97% and S&P BSE Bankex, up 0.62%.
S&P BSE IT was the major loser, down 1.55% followed by S&P BSE Teck,
down 1.21% and S&P BSE Oil & Gas, down 0.95%.
The International Monetary Fund (IMF) in its World Economic Outlook
projected the growth of the Indian economy to contract 4.5% in FY21. This
is in sharp contrast to its projection made in Apr 2020 when the IMF
projected the Indian economy to grow 1.9% in this fiscal. The downgrade
comes as the IMF took into account an extended lockdown period and a
slower than anticipated recovery. IMF also downgraded its growth forecast
for the Indian economy to 6.0% for the next fiscal, down 1.4 percentage
points from its projection of a growth of 7.4% it made in Apr 2020.
According to the Chief of Federation of Indian Export Organization (FIEO),
exports from the country are likely to come down by 10% to 12% on a
yearly basis in this fiscal. The slump is expected to come due to a
contraction in global demand on account of the COVID-19 pandemic.
Capital market regulator Securities and Exchange Board of India made
amendments to the insider trading prohibition rules. The amendments
include maintenance of a structured digital database that will contain the
nature of the unpublished price sensitive information along with the names
of those who shared the information. In addition, it will also include
automation of process of making disclosures to the stock exchanges,
restriction on trading window not to be made applicable for transactions as
mandated by the capital market regulator and also takes into account the
entities that need to file the non-compliance of code of conduct with the
stock exchanges.
GAIL reported 62% increase in its consolidated profit before tax (PBT) in
quarter ended Mar 2020 to Rs. 3,598.7 crore as against Rs. 2,226.8 crore
during the same period last year. The consolidated revenue for the period
under review fell 6% to Rs 17,938 crore in quarter ended Mar 2020 from Rs.
19,078.3 crore during the quarter ended Mar 2019.
According to media reports, Aurobindo Pharma is developing a variety of
drugs including 14 biosimilars as it aims to broaden its portfolio of products
in the U.S. and EU markets.
Asian markets closed in the red as reports of spike in new covid-19 cases in
several U.S. states and elsewhere fuelled concerns over the efforts by
governments to reopen economies and ease lockdown restrictions. Today
(as on Jun 26), markets traded mixed as concerns over fresh covid-19 cases
worldwide is neutralised by positive cues generated from overnight gains in
the Wall Street. While Nikkei is up 0.96%, Hang Seng is down 0.44% (as at
8:00 AM IST).
European markets closed in the green despite surging new coronavirus
cases in the U.S. and gloomy global economic growth outlook by IMF.
Investors took positive cues from gains in the U.S. markets.
U.S. markets closed higher with investors taking positive cues from the
news that U.S. regulators plan to ease banking regulations, thereby
allowing them to invest in riskier funds and to avoid building up cash
safeguards against certain derivatives trades.
Markets for You